Institutional Ownership Cytom X Therapeutics, Inc. (CTMX)
This table provides information about the institutional ownership of Cytom X Therapeutics, Inc. (CTMX). We have compiled data on the 109 institutions that hold shares in the stock, with a total of 121 Million shares, which have been reported (via 13F filing form) to have a value of $465 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Exome Asset Management LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
745,305
shares
|
$2.88 Million
1.44% of portfolio
|
Q3 2025
New holding
|
|
|
Assenagon Asset Management S.A.
|
Oct 07, 2025 Q3 2025 |
729,967
shares
|
$2.82 Million
0.0% of portfolio
|
Q3 2025
Added 1.38%
|
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
729,698
shares
|
$2.82 Million
0.0% of portfolio
|
Q3 2025
Added 362.77%
|
|
|
Acadian Asset Management LLC
Boston, MA |
Nov 13, 2025 Q3 2025 |
653,725
shares
|
$2.52 Million
0.0% of portfolio
|
Q3 2025
Reduced 58.01%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2025 Q3 2025 |
644,982
shares
|
$2.49 Million
0.0% of portfolio
|
Q3 2025
Added 0.93%
|
|
|
Prosight Management, LP
Dallas, TX |
Nov 14, 2025 Q3 2025 |
564,800
shares
|
$2.18 Million
0.48% of portfolio
|
Q3 2025
Reduced 83.94%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 07, 2025 Q3 2025 |
535,974
shares
|
$2.07 Million
0.14% of portfolio
|
Q3 2025
Reduced 15.03%
|
|
|
Inspire Investing, LLC
Meridian, ID |
Oct 15, 2025 Q3 2025 |
522,482
shares
|
$2.02 Million
0.17% of portfolio
|
Q3 2025
New holding
|
|
|
Dimensional Fund Advisors LP
Austin, TX |
Nov 12, 2025 Q3 2025 |
451,128
shares
|
$1.74 Million
0.0% of portfolio
|
Q3 2025
Added 146.29%
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2025 Q3 2025 |
447,753
shares
|
$1.73 Million
0.0% of portfolio
|
Q3 2025
Added 2950.5%
|
|
|
First Trust Advisors LP
Wheaton, IL |
Nov 12, 2025 Q3 2025 |
401,891
shares
|
$1.55 Million
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Jane Street Group, LLC
New York, NY |
Nov 13, 2025 Q3 2025 |
401,367
shares
|
$1.55 Million
0.0% of portfolio
|
Q3 2025
Added 3253.67%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 14, 2025 Q3 2025 |
389,685
shares
|
$1.5 Million
0.0% of portfolio
|
Q3 2025
Reduced 13.42%
|
|
|
Morgan Stanley
New York, NY |
Nov 14, 2025 Q3 2025 |
319,288
shares
|
$1.23 Million
0.0% of portfolio
|
Q3 2025
Reduced 5.87%
|
|
|
Raymond James Financial Inc
St. Petersburg, FL |
Nov 14, 2025 Q3 2025 |
293,560
shares
|
$1.13 Million
0.0% of portfolio
|
Q3 2025
Added 3.53%
|
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2025 Q3 2025 |
267,485
shares
|
$1.03 Million
0.0% of portfolio
|
Q3 2025
Reduced 8.36%
|
|
|
High Vista Strategies LLC
Boston, MA |
Nov 14, 2025 Q3 2025 |
257,148
shares
|
$992,591
0.25% of portfolio
|
Q3 2025
New holding
|
|
|
Precision Wealth Strategies, LLC
|
Oct 16, 2025 Q3 2025 |
237,081
shares
|
$915,132
0.28% of portfolio
|
Q3 2025
New holding
|
|
|
Prelude Capital Management, LLC
New York, NY |
Nov 14, 2025 Q3 2025 |
206,526
shares
|
$797,190
0.06% of portfolio
|
Q3 2025
New holding
|
|
|
Diadema Partners LP
Morristown, NJ |
Nov 14, 2025 Q3 2025 |
185,286
shares
|
$715,203
0.15% of portfolio
|
Q3 2025
New holding
|
|
|
Ameriprise Financial Inc
Minneapolis, MN |
Nov 14, 2025 Q3 2025 |
158,329
shares
|
$611,149
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Royal Bank Of Canada
Toronto, A6 |
Nov 14, 2025 Q3 2025 |
152,304
shares
|
$587,893
0.0% of portfolio
|
Q2 2025
Added 59.91%
|
|
|
Quadrature Capital LTD
London, X0 |
Nov 13, 2025 Q3 2025 |
125,035
shares
|
$482,635
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Stonepine Capital Management, LLC
Bend, OR |
Nov 13, 2025 Q3 2025 |
125,000
shares
|
$482,500
0.32% of portfolio
|
Q3 2025
New holding
|
|
|
Qube Research & Technologies LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
122,500
shares
|
$472,850
0.0% of portfolio
|
Q3 2025
New holding
|
|